Autism Spectrum Disorder
Research Study
Research Study
Researchers at UMass Chan Medical School are investigating how to improve the care of children and families affected by neurodevelopmental challenges such as autism and Fragile X.
13 - 17
Years Old
Years Old
Conducted in Worcester, MA
Diagnosis of Autism
Compensation Provided
Able to have an MRI Scan
Fast Facts
About Our Research Study
The purpose of this study is to see if an investigational medication is effective for individuals with autism spectrum disorder. This study aims to determine whether the study drug gabapentin changes the amount of GABA in the brain. We will also study whether this study drug has any benefit on social communication in adolescents with ASD. |
Additional Information
This study aims to determine whether the study drug gabapentin changes the amount of GABA in the brain.
We will also study whether this study drug has any benefit on social communication in adolescents with ASD.
We will also study whether this study drug has any benefit on social communication in adolescents with ASD.
Your child may qualify for this study if meet the following criteria.
Inclusion Criteria:
Inclusion Criteria:
- Have an ASD Diagnosis
- Between the Ages of 13 and 17
- No major medical, psychiatric or neurological disorders
- No substance use disorder, No usage of Gabapentin
All Participants will:
- Be in this research study for approximately 8-10 weeks which includes 6-7 visits.
- Take a study drug called gabapentin three times a day for 8 weeks.
- Have three MRI scans during the study and two blood draws.
- Have a Comprehensive Psychiatric Assessment, and Measures of Social Cognition
You will be compensated for time and travel
There is no cost for you to participate in this study.